ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sanofi and Regeneron receive CHMP positive opinion for rheumatoid arthritis treatment
May 02, 2017The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the marketing authorisation of Sanofi and Regeneron Pharmaceuticals’ Kevzara (sarilumab). -
BioMarin’s Brineura receives positive opinion from CHMP to treat CLN2 disease
April 25, 2017BioMarin Pharmaceutical has announced that European Medicines Agency’s (EMA) Committee for Medicinal Products... -
CHMP backs 11 medicines for European approval
April 25, 2017Eleven new medicines have taken a giant leap towards approval in Europe after winning backing from the European ... -
AbbVie receives CHMP positive opinion for Hep C tablet combination
March 03, 2017The European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for Abbvie’s shorter, eight-week treatment of Viekirax... -
Janssen’s monoclonal antibody receives positive CHMP opinion to treat multiple myeloma
March 01, 2017The Committee for Medicinal products for human use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for Janssen‘s Darzalex (daratumumab). -
AbbVie Receives CHMP Positive Opinion for Eight-Week Treatment Option with VIEKIRAX® + EXVIERA®
AbbVie announced that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for a shorter,
-
DARZALEX® Receives Positive CHMP Opinion for the Treatment of Multiple Myeloma
February 27, 2017Janssen-Cilag International NV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorization for DARZALEX®▼ (daratumumab).
Pharma Sources Insight January 2025
